EXCLUSIVE: Avalon's Lab Services MSO Poised To Commercialize FDA-Registered External Male Catheter Device
Portfolio Pulse from Vandana Singh
Avalon GloboCare Corp. (NASDAQ:ALBT) announced that Laboratory Services MSO, LLC, in which Avalon holds a 40% interest, has begun manufacturing the GeeWhiz External Condom Catheter, an FDA-registered male incontinence device. The product is set to launch in Q3 2024. The global male urinary incontinence market is expected to grow significantly. Avalon has also launched a DNA test for opioid dependence and extended a distribution agreement for a breathalyzer device.
August 14, 2024 | 11:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avalon GloboCare Corp. (NASDAQ:ALBT) announced the manufacturing of the GeeWhiz External Condom Catheter, an FDA-registered male incontinence device, with sales expected to start in Q3 2024. The global male urinary incontinence market is growing, which could positively impact Avalon's revenue.
The announcement of the GeeWhiz External Condom Catheter, an FDA-registered device, positions Avalon GloboCare to tap into the growing male urinary incontinence market. The expected launch in Q3 2024 and the device's approval for Medicare and private insurance reimbursement are likely to boost revenue and investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100